The Goldman Sachs Group Raises Oscar Health (NYSE:OSCR) Price Target to $16.00

Oscar Health (NYSE:OSCRFree Report) had its price objective raised by The Goldman Sachs Group from $8.00 to $16.00 in a report released on Friday morning, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock.

Separately, Bank of America upgraded shares of Oscar Health from a neutral rating to a buy rating and lifted their target price for the stock from $8.00 to $9.00 in a research report on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Hold and a consensus price target of $9.40.

Read Our Latest Stock Report on Oscar Health

Oscar Health Price Performance

Shares of OSCR opened at $17.68 on Friday. Oscar Health has a twelve month low of $3.22 and a twelve month high of $17.99. The firm’s fifty day simple moving average is $10.36 and its 200-day simple moving average is $7.84. The firm has a market capitalization of $4.00 billion, a price-to-earnings ratio of -14.73 and a beta of 1.72. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.32.

Oscar Health (NYSE:OSCRGet Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 28.95%. The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period last year, the business earned ($1.05) EPS. Oscar Health’s revenue for the quarter was up 43.9% compared to the same quarter last year. Equities analysts forecast that Oscar Health will post 0.04 EPS for the current fiscal year.

Insider Activity at Oscar Health

In related news, CFO Richard Scott Blackley sold 30,029 shares of the company’s stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $245,036.64. Following the sale, the chief financial officer now directly owns 548,613 shares of the company’s stock, valued at $4,476,682.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Richard Scott Blackley sold 30,029 shares of the stock in a transaction dated Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $245,036.64. Following the sale, the chief financial officer now owns 548,613 shares of the company’s stock, valued at approximately $4,476,682.08. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Mario Schlosser sold 390,405 shares of the stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $7.12, for a total transaction of $2,779,683.60. Following the completion of the transaction, the insider now owns 57,317 shares of the company’s stock, valued at approximately $408,097.04. The disclosure for this sale can be found here. Insiders have sold 437,227 shares of company stock valued at $3,161,751 over the last ninety days. Corporate insiders own 25.54% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. Covestor Ltd boosted its position in shares of Oscar Health by 310.0% during the 2nd quarter. Covestor Ltd now owns 3,329 shares of the company’s stock valued at $27,000 after purchasing an additional 2,517 shares in the last quarter. CI Private Wealth LLC bought a new position in shares of Oscar Health during the 4th quarter valued at about $38,000. Royal Bank of Canada boosted its position in shares of Oscar Health by 959.5% during the 3rd quarter. Royal Bank of Canada now owns 10,129 shares of the company’s stock valued at $50,000 after purchasing an additional 9,173 shares in the last quarter. Dark Forest Capital Management LP boosted its holdings in shares of Oscar Health by 5,243.2% in the first quarter. Dark Forest Capital Management LP now owns 7,801 shares of the company’s stock worth $51,000 after buying an additional 7,655 shares during the period. Finally, Alpine Global Management LLC acquired a new position in shares of Oscar Health in the fourth quarter worth about $54,000. Institutional investors own 66.70% of the company’s stock.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.

Further Reading

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.